Filipa Guerreiro is a PhD student at the University of Algarve, in Portugal. She has graduated in Biomedical Sciences and has a Master in the same area. She is enrolled in the last year of a PhD program, with a project aimed at the development of an inhalable formulation to target alveolar macrophages for the treatment of pulmonary tuberculosis. At this moment, Filipa has published 4 papers and this is her 4th participation on the DDL Conference. She has participated in several international conferences in the area of drug delivery, presenting 9 poster communications. Her first oral presentation was last year in DDL Conference as finalist of Pat Burnell award.